“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease

Small ubiquitin-like modifier 4 ( SUMO4 ) has been shown to have the potential to down-regulate NF-κB signal, leading to decreased transcription of pro-inflammatory cytokines. Recently, SUMO4 polymorphisms have been shown to be associated with several autoimmune diseases. In the present study, the association of SUMO4 polymorphisms with Behcet's disease (BD) was investigated. Our results showed a significantly increased frequency of the + 438 C allele and a significantly decreased frequency of the AGAT haplotype in BD patients ( p = 0.0002, corrected p = 0.002; p = 0.000015, corrected p = 0.0002, respectively). Stratification analysis indicated that these significant associations only existed in the HLA-B51 negative subjects ( p = 0.004, corrected p = 0.032; p = 0.001, corrected p = 0.016, respectively). The GGAC haplotype was negatively associated with HLA-B51 positive BD patients ( p = 0.0007, corrected p = 0.011). In conclusion, SUMO4 + 438 C allele is associated with susceptibility to BD in HLA-B51 negative patients, while the AGAT haplotype is protectively associated with BD in HLA-B51 negative patients. The GGAC haplotype is protectively associated with BD in HLA-B51 positive patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Immunology Elsevier
Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.